DocGo’s (DCGO) “Overweight” Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of DocGo (NASDAQ:DCGO – Free Report) in a research note released on Friday, Benzinga reports. Cantor Fitzgerald currently has a $5.00 price objective on the stock. Separately, Needham & Company LLC restated a buy rating and set a $7.00 target price on shares of DocGo in a […]

Leave a Reply

Your email address will not be published.

Previous post Health Catalyst (NASDAQ:HCAT) Rating Reiterated by Cantor Fitzgerald
Next post Bank OZK (NASDAQ:OZK) Price Target Cut to $48.00